[go: up one dir, main page]

ES2147267T3 - Aplicacion de esteroides aromaticos sustituidos en posicion 3, con una cadena aminoalcoxi disustituida para obtener un medicamento destinado al control de la fertilidad en particular de la fertilidad masculina. - Google Patents

Aplicacion de esteroides aromaticos sustituidos en posicion 3, con una cadena aminoalcoxi disustituida para obtener un medicamento destinado al control de la fertilidad en particular de la fertilidad masculina.

Info

Publication number
ES2147267T3
ES2147267T3 ES95400630T ES95400630T ES2147267T3 ES 2147267 T3 ES2147267 T3 ES 2147267T3 ES 95400630 T ES95400630 T ES 95400630T ES 95400630 T ES95400630 T ES 95400630T ES 2147267 T3 ES2147267 T3 ES 2147267T3
Authority
ES
Spain
Prior art keywords
fertility
application
control
aminoalcoxy
disstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95400630T
Other languages
English (en)
Inventor
Armelle Bonfils
Daniel Philibert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Aventis Pharmaceuticals Inc
Original Assignee
Hoechst Marion Roussel
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel, Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel
Application granted granted Critical
Publication of ES2147267T3 publication Critical patent/ES2147267T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA INVENCION E REFIERE A LA APLICACION DE LOS COMPUESTOS DE FORMULA (I) EN LA QUE R1 Y R2 REPRESENTAN UN ALKILO DE 1 A 8 ATOMOS DE CARBONO O UN BENCILO, O FORMAN JUNTO CON EL NITROGENO AL QUE ESTAN UNIDOS UN HETEROCICLO SATURADO DE 5 O 6 ESLABONES R3 EN POSICION ALFA O BETA REPRESENTA UN METILO, N ESTA COMPRENDIDO ENTRE 2 Y 10, Y O R4 Y R5 FORMAN JUNTO UN OXO, O R4 REPRESENTA UN ATOMO DE HIDROGENO, UN GRUPO HIDROXILO O ACILOXI QUE TIENE A LO SUMO 12 ATOMOS DE CARBONO Y R5 REPREENTA UN ATOMO DE HIDROGENO, UN HIDROXILO, ACILOXI QUE TIENE A LO SUMO 12 ATOMOS DE CARBONO, ALKILO, ALCENILO O ALCINILO QUE TIENE CADA UNO A LO SUMO 8 ATOMOS DE CARBONO, R6 Y R7 FORMAN JUNTOS UN OXO O, IDENTICOS O DIFERENTES, REPRESENTAN UN ATOMO DE HIDROGENO, UN HIDROXILO O ACILOXI, O, R5 Y R6 FORMAN JUNTOS UN DOBLE ENLACE Y R4 Y R7 SON ATOMOS DE HIDROGENO, ASI COMO SUS SALES DE ADICION CON LOS ACIDOS FARMACEUTICAMENTE ACEPTABLES, PARA OBTENER UN MEDICAMENTO DESTINADO AL CONTROL DE LA FERTILIDAD Y EN PARTICULAR AL CONTROL DE LA FERTILIDAD MASCULINA.
ES95400630T 1994-03-24 1995-03-22 Aplicacion de esteroides aromaticos sustituidos en posicion 3, con una cadena aminoalcoxi disustituida para obtener un medicamento destinado al control de la fertilidad en particular de la fertilidad masculina. Expired - Lifetime ES2147267T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9403460A FR2717690B1 (fr) 1994-03-24 1994-03-24 Application de stéroïdes aromatiques 3 substitués par un aminoalcoxy substitué à l'obtention d'un médicament pour contrôler la stérilité, notamment masculine.

Publications (1)

Publication Number Publication Date
ES2147267T3 true ES2147267T3 (es) 2000-09-01

Family

ID=9461385

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95400630T Expired - Lifetime ES2147267T3 (es) 1994-03-24 1995-03-22 Aplicacion de esteroides aromaticos sustituidos en posicion 3, con una cadena aminoalcoxi disustituida para obtener un medicamento destinado al control de la fertilidad en particular de la fertilidad masculina.

Country Status (16)

Country Link
US (5) US5554604A (es)
EP (1) EP0676202B1 (es)
JP (1) JP3678454B2 (es)
KR (1) KR100367805B1 (es)
CN (1) CN1055391C (es)
AT (1) ATE193650T1 (es)
AU (1) AU698349B2 (es)
CA (1) CA2145469A1 (es)
DE (1) DE69517356T2 (es)
DK (1) DK0676202T3 (es)
ES (1) ES2147267T3 (es)
FR (1) FR2717690B1 (es)
GR (1) GR3033882T3 (es)
HU (1) HUT72085A (es)
PT (1) PT676202E (es)
RU (1) RU2176506C2 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2742337B1 (fr) * 1995-12-13 1998-03-06 Roussel Uclaf Application du 3-alpha-hydroxy-5-alpha-androsta-16-ene a titre de medicaments
US5834225A (en) * 1997-01-15 1998-11-10 Board Of Trustees Operating Michigan State University Method, device and test kit for capacitation of sperm
DE19917930A1 (de) * 1999-04-15 2000-10-19 Schering Ag Ent-Steroide als selektiv wirksame Estrogene
EP1330467B1 (en) * 2000-11-03 2007-05-02 Washington University Modified, hydroxy-substituted aromatic structures having cytoprotective activity
US20020132802A1 (en) * 2000-11-17 2002-09-19 Washington Univeristy Cytoprotective polycyclic compounds
JP4045090B2 (ja) * 2001-11-06 2008-02-13 オムロン株式会社 静電アクチュエータの調整方法
US7687486B2 (en) * 2003-04-29 2010-03-30 Florida Agricultural & Mechanical University Selective estrogen receptor modulators
US10397672B2 (en) 2016-06-20 2019-08-27 Cable Television Laboratories, Inc. Systems and methods for intelligent edge to edge optical system and wavelength provisioning

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL120166C (es) * 1961-08-11
FR1338308A (fr) * 1961-08-11 1963-09-27 Roussel Uclaf Stéroïdes aromatiques substitués en position 3 et procédé de préparation
GB984029A (en) * 1963-01-17 1965-02-24 Parke Davis & Co Estrone derivatives and methods for their production
GB984028A (en) * 1963-01-17 1965-02-24 Parke Davis & Co Estradiol derivatives and methods for their production
US3519714A (en) * 1966-03-15 1970-07-07 Herchel Smith Synthesis of gona-1,3,5(10)-trienes
FR2640977A2 (en) * 1982-06-11 1990-06-29 Roussel Uclaf New position-11 substituted 19-norsteroids and their application as medicinal products.
SE8802402D0 (sv) * 1988-06-28 1988-06-28 Pharmacia Ab Novel esters
GB9226489D0 (en) * 1992-12-19 1993-02-10 Univ Manchester A joint
KR100984028B1 (ko) * 2008-01-06 2010-10-01 전현철 새콤달콤한 조성물을 난(卵)에 전이하여 구운 새로운 향미의 도포 난(卵) 제조방법
KR102037155B1 (ko) * 2018-11-28 2019-10-28 김훈 다중 레이어를 갖는 프라모델 완성품 보관 및 전시케이스

Also Published As

Publication number Publication date
DE69517356T2 (de) 2000-12-14
US5635498A (en) 1997-06-03
US5739124A (en) 1998-04-14
CA2145469A1 (fr) 1995-09-25
CN1111988A (zh) 1995-11-22
US5672595A (en) 1997-09-30
DE69517356D1 (de) 2000-07-13
RU2176506C2 (ru) 2001-12-10
JPH07285988A (ja) 1995-10-31
EP0676202A2 (fr) 1995-10-11
RU95104235A (ru) 1996-11-27
AU1495695A (en) 1995-10-05
ATE193650T1 (de) 2000-06-15
FR2717690A1 (fr) 1995-09-29
JP3678454B2 (ja) 2005-08-03
KR100367805B1 (ko) 2003-08-02
DK0676202T3 (da) 2000-10-16
HUT72085A (en) 1996-03-28
FR2717690B1 (fr) 1996-04-26
KR950031078A (ko) 1995-12-18
US5580864A (en) 1996-12-03
US5554604A (en) 1996-09-10
AU698349B2 (en) 1998-10-29
HU9500846D0 (en) 1995-05-29
CN1055391C (zh) 2000-08-16
EP0676202A3 (fr) 1995-12-27
GR3033882T3 (en) 2000-11-30
PT676202E (pt) 2000-09-29
EP0676202B1 (fr) 2000-06-07

Similar Documents

Publication Publication Date Title
ES2064517T3 (es) Compuestos de piridinosulfonamida sustituida, composicion herbicida que los contiene y metodo para la preparacion de estos compuestos.
ES2071989T3 (es) Analogos de oligonucleotidos.
ES2036551T3 (es) Compuestos heterociclicos.
ES2121836T3 (es) Aminoguanidinas.
ES2176329T3 (es) Procedimientos para preparar formas anhidras e hidratadas de derivados antihistaminicos de piperidina, sus polimeros y pseudomorfos.
ES2170063T3 (es) Derivados 5-espiro-substituidos de 1-h-3-aril-pirrolidin-2,4-diona como herbicidas, insecticidas y acaricidas.
ES2190790T3 (es) Derivados del acido 3-aril-tetronico, su obtencion y su empleo como agentes pesticidas.
ES2101258T3 (es) Derivados de pirazol; procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ES2045041T3 (es) Triazolinonas sustituidas.
ES2097409T3 (es) Benzoilguanidinas, procedimiento para su preparacion, asi como su empleo como antiarritmicos.
ES474592A1 (es) Procedimiento para la preparacion de derivados de imidazoli-nina
ES2147267T3 (es) Aplicacion de esteroides aromaticos sustituidos en posicion 3, con una cadena aminoalcoxi disustituida para obtener un medicamento destinado al control de la fertilidad en particular de la fertilidad masculina.
ES2118333T3 (es) Derivados del acido naftilacetico como agonistas y antagonistas de pgez.
ES8200679A1 (es) Un procedimiento para la preparacion de derivados de carboestirilo.
ES2070238T3 (es) Emulsion de lipidos que contiene un analogo de prostaglandina.
ES2043863T3 (es) Procedimiento para preparar derivados de la 1,2,5,6-tetrahidropiridina.
ES2096396T3 (es) Procedimiento para la obtencion de polimeros, formados por alqu-1-enos con 2 a 10 atomos de carbono con empleo de complejos de metaloceno racemicos como catalizadores.
ES2081314T3 (es) Compuestos de diaminoetileno.
ES2029879T3 (es) Procedimiento para producir derivados de aminas sustituidas.
ES2132651T3 (es) Derivados amidicos de la vitamina d.
ES8801622A1 (es) Un procedimiento para preparar derivados arilicos de dienamidas
ES2070002T3 (es) Composiciones terapeuticas a base de derivados de 1,2-ditiol-3-tiona.
ES2179864T3 (es) 4-benzoil-isoxazoles y su uso como herbicidas.
ES8401962A1 (es) Un procedimiento para la preparacion de un derivado de piridoindol.
ES2058849T3 (es) Benzanilidas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 676202

Country of ref document: ES